It is currently Sun Jul 27, 2014 9:34 pm

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

New Autoinjection Device, Betaject(R) 3

New Autoinjection Device Designed to Work With Betaseron(R) Now Available For Patients With Multiple Sclerosis
Betaject(R)3 Offers Convenient Delivery Option


WAYNE, N.J., July 11 /PRNewswire/ -- Berlex, Inc. today announced the availability of Betaject(R) 3, a new autoinjection device specifically designed to work with Betaseron(R) (interferon beta-1b) as an optional injection method for patients with relapsing forms of multiple sclerosis (MS). The Betaject 3 autoinjection device is an easy-to-use, mechanical device that automatically delivers subcutaneous ...
Read more : New Autoinjection Device, Betaject(R) 3 | Views : 5700 | Replies : 2 | Forum : Betaseron


MS and cancer

I was wondering if anyone has come across any research linking MS and cancer or perhaps any of the MS drugs and cancer, (even more specifically breast cancer)? I have been hesitant to post this but need to research this now as I was very recently dx'd with breast cancer. Fortunately it was caught very, very early. I just want to see if there is any possible link or if it is just very bad ...
Read more : MS and cancer | Views : 2327 | Replies : 11 | Forum : General Discussion


Environmental factors, Australia Research

There is convincing evidence that environmental factors are contributing to the rise in autoimmune diseases like Multiple Sclerosis, Crohn’s disease and Type 1 diabetes around the world. A study coordinated at ANU is set to discover what some of these factors might be.

Teams of medical scientists worldwide are searching for cures for autoimmune diseases like Type 1 diabetes, Multiple Sclerosis and Crohn’s disease. While this worthy activity progresses, there is a quiet anticipation elsewhere ...
Read more : Environmental factors, Australia Research | Views : 1145 | Replies : 1 | Forum : General Discussion




IL23

Archemix Announces Strategic Alliance With Elan to Discover and Develop Aptamer Therapeutics

Archemix Corp. announced today a multi-year, multi-product alliance with Elan Corporation plc focused on the discovery, development, and commercialisation of first-in-class aptamer therapeutics to treat autoimmune disease. The companies will seek to develop aptamer therapeutics to IL-23, a cytokine that has emerged as a mediator in the chronic autoimmune inflammatory diseases, and additional protein targets. The collaboration combines Archemix's extensive expertise in aptamer ...
Read more : IL23 | Views : 797 | Replies : 0 | Forum : General Discussion


Silk

Another technology story. Perhaps they will repair us with silk and micro-chips in the future.

http://news.bbc.co.uk/1/hi/sci/tech/5172422.stm
Read more : Silk | Views : 839 | Replies : 0 | Forum : General Discussion


Overwhelming

Wow..
For a newbie, this is so overhwelming..... :cry:
Read more : Overwhelming | Views : 2729 | Replies : 4 | Forum : Tysabri (Antegren or Natalizumab)




Brain chip

MS news is thin on the ground and August / September are quiet months before the ECTRIMS and ACRIMS (Oct) conferences take place and new research / trial results are released.

Technological advances continue - the BBC website reported today that scientists were developing a retina which could be attached to the optic nerves and give people back their site (probably within ten years). Another advance reported today was a brain chip which would help ...
Read more : Brain chip | Views : 910 | Replies : 0 | Forum : General Discussion


Update: you may or may not know

I spoke with our DR about setting up appt on infusion. The DR in Memphis is awaiting training to be certified. I call the 800# for financial assistance, just getting everything ready. Was told that Tysabri is not commercially available yet, but will be most likely this month. They are awaiting approval from the FDA on training materials for the infusion sites so they can turn around and certify them. Looks like last of July ...
Read more : Update: you may or may not know | Views : 1528 | Replies : 1 | Forum : Tysabri (Antegren or Natalizumab)


 

Login  •  Register


Statistics

Total posts 218706 • Total topics 22538 • Total members 14186